Pluri Inc PLUR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:00 AM EDT
0.82quote price arrow down-0.0598 (-6.797%)
Volume
540
Close
0.8798quote price arrow down-0.1402 (-13.7451%)
Volume
417,904
52 week range
0.43 - 1.07
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.8798
  • 52 Week High1.07
  • 52 Week High Date07/11/23
  • 52 Week Low0.43
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap36.494M
  • Shares Out41.48M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.46
  • YTD % Change51.82

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.8798
  • 52 Week High1.07
  • 52 Week High Date07/11/23
  • 52 Week Low0.43
  • 52 Week Low Date10/27/23
  • Market Cap36.494M
  • Shares Out41.48M
  • 10 Day Average Volume0.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.46
  • YTD % Change51.82

RATIOS/PROFITABILITY

  • EPS (TTM)-4.75
  • P/E (TTM)-0.19
  • Fwd P/E (NTM)-0.95
  • EBITDA (TTM)-23.938M
  • ROE (TTM)-175.64%
  • Revenue (TTM)356,999.993
  • Gross Margin (TTM)28.57%
  • Net Margin (TTM)-6,850.42%
  • Debt To Equity (MRQ)554.69%

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pluri Inc

 

Profile

MORE
Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based...
Zalman Aberman
Chairman of the Board
Yaky Yanay
President, Chief Executive Officer, Director
Chen Franco-Yehuda
Chief Financial Officer, Treasurer, Secretary
Address
Matam Park Building 5
Haifa
3508409
Israel

Top Peers

SYMBOLLASTCHG%CHG
VIRX
Viracta Therapeutics Inc
1.08UNCHUNCH
TCRT
Alaunos Therapeutics Inc
1.86-0.03-1.59%
CADL
Candel Therapeutics Inc
1.54+0.05+3.36%
CALC
CalciMedica Inc
4.19UNCHUNCH
EFTR
eFFECTOR Therapeutics Inc
13.45+0.54+4.18%